# Concern Foundation

Grantmaking public charity, Los Angeles, California. EIN 23-7002878.

Source: the foundation’s own IRS returns, read November 20, 2026, as shown by the Alleviate Index. https://sites.alleviate.org/index/funder/concern-foundation-237002878

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Concern Foundation accepts applications.

## What it gave

- Grants paid: $1,807,000 (Year ending December 2024)
- Grants listed: 23 (To organizations, on that return)
- Typical grant: $75,000 (Half fall between $25,000 and $75,000)

- December 2024: Grants paid $1,807,000; Grants listed 23
- December 2023: Grants paid $1,434,781; Grants listed 21

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

## What it funds, and where

- Focus, by share of linked grant dollars: Education 48%, Medical research 27%, Health care 12%, Philanthropy and grantmaking 6%, Disease and disorders 6%
- Where it gave, by number of grants: California 25, District of Columbia 2, New York 2, Oregon 2, Pennsylvania 2, Texas 2, Missouri 2, Ohio 1, Michigan 1, Massachusetts 1, Illinois 1, Utah 1

## Recent grants to organizations

- CHILDRENS HOSPITAL LOS ANGELES (Los Angeles, California): $150,000, year ending December 2024. NOVEL MOLECULAR MECHANISM(S) OF P1D1 FUNCTION IN PEDIATRIC BRAIN TUMORS.
- USC NORRIS COMPREHENSIVE CANCER CENTER (Los Angeles, California): $100,000, year ending December 2024. ETHNIC DIFFERENCES IN IMMUNE RESPONSES AMONG BREAST CANCER PATIENTS
- CHILDREN'S HOSPITAL LOS ANGELES (Los Angeles, California): $90,000, year ending December 2024. SUMMER ONCOLOGY RESEARCH FELLOWSHIP PROGRAM
- CHILDREN'S HOSPITAL LOS ANGELES (Los Angeles, California): $75,000, year ending December 2024. ELUCIDATING THE MECHANISM OF CHROMOSOME 17Q GAIN-MEDIATED NEUROBLASTOMA TUMORIGENESIS
- MEMORIAL SLOAN KETTERING CANCER CENTER (New York, New York): $75,000, year ending December 2024. EARLY TRANSCRIPTIONAL, EPIGENETIC, AND ENVIRONMENTAL FACTORS OF SQUAMOUS TRANSFORMATION IN LUNG CANCER
- OHIO STATE UNIVERSITY (Columbus, Ohio): $75,000, year ending December 2024. TARGETING A NEW IMMUNE CHECKPOINT AXIS (PILRCD8) TO TREAT GLIOBLASTOMA
- OREGON HEALTH & SCIENCE UNIVERSITY (Portland, Oregon): $75,000, year ending December 2024. ANTIGEN SORTING BY DENDRITIC CELLS IMPACTS ANTI-TUMOR IMMUNITY
- OREGON HEALTH AND SCIENCE UNIVERSITY (Portland, Oregon): $75,000, year ending December 2024. REPROGRAMMING SUPPRESSIVE REGULATORY T CELLS IN THE TUMOR MICROENVIRONMENT
- TEMPLE UNIVERSITY (Philadelphia, Pennsylvania): $75,000, year ending December 2024. ROLE OF CHEMOTHERAPY IN PROMOTING AWAKENING OF DORMANT TUMOR CELLS AND METASTATIC RELAPSE
- THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (Houston, Texas): $75,000, year ending December 2024. TARGETING COLLAGEN I HOMOTRIMER INDUCED IL-18 AS A NOVEL THERAPEUTIC STRATEGY IN PANCREATIC CANCER
- [The Wistar Institute of Anatomy and Biology](https://sites.alleviate.org/index/org/the-wistar-institute-of-anatomy-and-biology-236434390) (Philadelphia, Pennsylvania): $75,000, year ending December 2024. MYELOID CELL-DERIVED INTERLEUKIN 1B PROMOTES CHEMORESISTANCE IN METASTATIC OVARIAN CANCER.
- UT MD ANDERSON CANCER CENTER (Houston, Texas): $75,000, year ending December 2024. ELUCIDATING THE MOLECULAR AND CELLULAR PATHOGENESIS OF ENDOGENOUS RETROVIRUSES IN SKIN CANCER
- WASHINGTON UNIVERSITY (St Louis, Missouri): $75,000, year ending December 2024. TARGETING MECHANISMS OF TUMOR IMMUNE EVASION IN CERVICAL CANCER
- U-GROW PROGRAM CEDARS SINAI MEDICAL CENTER (Los Angeles, California): $50,000, year ending December 2024. FOR THE U GROW PROGRAM PREPARING FUTURE SCIENTISTS FOR GRADUATE SCHOOL
- [Beauty Bus Foundation](https://sites.alleviate.org/index/org/beauty-bus-foundation-263075655) (Los Angeles, California): $45,000, year ending December 2024. POP-UP EVENTS FOR THE CANCER COMMUNITY
- [Hope for Henry Foundation](https://sites.alleviate.org/index/org/hope-for-henry-foundation-200244173) (Washington, District of Columbia): $30,000, year ending December 2024. TO EXPAND THE HOPE FOR HENRYS HIGH-IMPACT AND IN-DEMAND SUPER REWARDS FOR SUPER KIDS PROGRAM TO ONE NEW HOSPITAL.
- CHILDREN'S HOSPITAL LOS ANGELES (Los Angeles, California): $25,000, year ending December 2024. EVALUATION OF A NOVEL CELLULAR THERAPY FOR CHILDREN AND YOUNG ADOLESCENTS WITH HIGH-GRADE GLIOMA BRAIN TUMORS
- [Jewish Community FDN of the Jewish Federation Council of Greater La](https://sites.alleviate.org/index/org/jewish-community-fdn-of-the-jewish-federation-council-of-956111928) (Los Angeles, California): $25,000, year ending December 2024. TO COVER BUSY BOX AND THRIVING AGAIN KITS
- UROLOGIC HEALTH PROGRAM PROVIDENCE ST JOSEPH'S MEDICAL CENTER DISNEY FAMIL (Burbank, California): $25,000, year ending December 2024. TO COVER UROLOGIC ONCOLOGY PROGRAMS AT THE DISNEY CANCER CENTER
- USC NORRIS COMPREHENSIVE CANCER CENTER (Los Angeles, California): $25,000, year ending December 2024. TO EXPAND THE ADOLESCENT AND YOUNG ADULT CANCER PROGRAM AT USC
- USC NORRIS HEAD & NECK CANCER (Los Angeles, California): $25,000, year ending December 2024. TO SUPPORT A NOVEL HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) IMMUNOTHERAPY STUDY USING BOTH ANIMAL MODELS AND PATIENT-DERIVED TUMOR ORGANOIDS
- CITY OF HOPE (Duarte, California): $22,000, year ending December 2024. PANCREATIC DUCTAL ADENOCARCINOMA- COLLECTING PLASMA WITH PANCREATIC CANCER AND THOSE IN HIGH RISK OF DEVELOPING THE DISEASE
- CEDARS SINAI MEDICAL CENTER (Los Angeles, California): $20,000, year ending December 2024. TO COVER SERVICES AND WORKSHOPS FOR THE WELLNESS, RESILIENCE, AND SURVIVORSHIP PROGRAM
- CHILDREN'S HOSPITAL LOS ANGELES USC (Los Angeles, California): $225,000, year ending December 2023. FLIP-FLOPPING OF FUSION-POSITIVE RHABDOMYOSARCOMA LEADING TO METASTATIC INVASION
- [University of Southern California](https://sites.alleviate.org/index/org/university-of-southern-california-951642394) (Los Angeles, California): $100,000, year ending December 2023. ETHNIC DIFFERENCES AMONG BREAST CANCER PATIENT IMMUNE RESPONSES

Method and sources: https://sites.alleviate.org/index/method#funders
